These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7816300)

  • 21. Serum IgA and the production of IgA by peripheral blood and bone marrow lymphocytes in patients with primary IgA nephropathy: evidence for the bone marrow as the source of mesangial IgA.
    van den Wall Bake AW; Daha MR; Evers-Schouten J; van Es LA
    Am J Kidney Dis; 1988 Nov; 12(5):410-4. PubMed ID: 3189325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Light-chain composition of serum IgA1 and in vitro IgA1 production in IgA nephropathy.
    Chen N; Nusbaum P; Halbwachs-Mecarelli L; Lesavre P
    Nephrol Dial Transplant; 1991; 6(11):846-50. PubMed ID: 1775249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sialylation of IgG inhibits the formation of galactose-deficient IgA1-containing immune complexes and protects mesangial cells from injury in IgA nephropathy.
    Liu Y; Li H; Yu H; Wang F; Jia J; Yan T
    BMC Nephrol; 2022 Jan; 23(1):25. PubMed ID: 35016642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defective immunoglobulin A (IgA) glycosylation and IgA deposits in patients with IgA nephropathy.
    Kolka R; Valdimarsson H; Bodvarsson M; Hardarson S; Jonsson T
    APMIS; 2013 Sep; 121(9):890-7. PubMed ID: 23398317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis.
    Dong J; Peng T; Gao J; Jia X; Yan G; Wang Y
    BMC Immunol; 2018 Jun; 19(1):18. PubMed ID: 29925312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytokine-induced immunoglobulin production in primary IgA nephropathy.
    van den Wall Bake AW; Crowley-Nowick PA; Kulhavy R; Hermans J; Jackson S; Julian BA; Mestecky J
    Am J Kidney Dis; 1992 Dec; 20(6):611-7. PubMed ID: 1462991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymeric IgA and immune complex concentrations in IgA-related renal disease.
    Jones CL; Powell HR; Kincaid-Smith P; Roberton DM
    Kidney Int; 1990 Aug; 38(2):323-31. PubMed ID: 2205751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of IgA1-dominant immune complexes in peripheral blood polymorphonuclear leukocytes by double immunofluorescence in patients with IgA nephropathy.
    Tomino Y; Miura M; Suga T; Endoh M; Nomoto Y; Sakai H
    Nephron; 1984; 37(2):137-9. PubMed ID: 6374482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunological abnormalities in family members of patients with IgA nephropathy.
    Miyazaki M
    Jpn J Med; 1990; 29(5):469-77. PubMed ID: 1982451
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Dotz V; Visconti A; Lomax-Browne HJ; Clerc F; Hipgrave Ederveen AL; Medjeral-Thomas NR; Cook HT; Pickering MC; Wuhrer M; Falchi M
    J Am Soc Nephrol; 2021 Oct; 32(10):2455-2465. PubMed ID: 34127537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies.
    Tomana M; Novak J; Julian BA; Matousovic K; Konecny K; Mestecky J
    J Clin Invest; 1999 Jul; 104(1):73-81. PubMed ID: 10393701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IgA-containing circulating immune complexes in patients with igA nephropathy.
    Hall RP; Stachura I; Cason J; Whiteside TL; Lawley TJ
    Am J Med; 1983 Jan; 74(1):56-63. PubMed ID: 6849328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IgA-containing immune complexes in the urine of IgA nephropathy patients.
    Matousovic K; Novak J; Yanagihara T; Tomana M; Moldoveanu Z; Kulhavy R; Julian BA; Konecny K; Mestecky J
    Nephrol Dial Transplant; 2006 Sep; 21(9):2478-84. PubMed ID: 16757497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Striking elevation of serum IgA, IgA-containing immune complexes, and IgA rheumatoid factor in clinically silent dermatitis herpetiformis.
    Julian BA; Czerkinsky C; Russell MW; Galla JH; Koopman WJ; Mestecky J; Moldoveanu Z; Jackson S
    Am J Kidney Dis; 1987 Nov; 10(5):378-84. PubMed ID: 3674013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum IgA1 and IgA2 in normal adults and patients with systemic lupus erythematosus and hepatic disease.
    Conley ME; Koopman WJ
    Clin Immunol Immunopathol; 1983 Mar; 26(3):390-7. PubMed ID: 6872349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro regulation of IgA subclass synthesis. II. The source of IgA2 plasma cells.
    Conley ME; Bartelt MS
    J Immunol; 1984 Nov; 133(5):2312-6. PubMed ID: 6332844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Galactose-deficient IgA1 in African Americans with IgA nephropathy: serum levels and heritability.
    Hastings MC; Moldoveanu Z; Julian BA; Novak J; Sanders JT; McGlothan KR; Gharavi AG; Wyatt RJ
    Clin J Am Soc Nephrol; 2010 Nov; 5(11):2069-74. PubMed ID: 20634323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated production of polymeric and monomeric IgA1 by the bone marrow in IgA nephropathy.
    van den Wall Bake AW; Daha MR; Haaijman JJ; Radl J; van der Ark A; van Es LA
    Kidney Int; 1989 Jun; 35(6):1400-4. PubMed ID: 2770118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune characteristics of renal allograft donors with mesangial IgA deposition.
    Wang Z; Zhang X; Han W; Yu G; Ying Z; Xu X; Wang M; Zhou X; Lv J; Zhang H
    Int Immunopharmacol; 2021 Feb; 91():107282. PubMed ID: 33370682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IgA nephropathy enigma.
    Mestecky J; Novak J; Moldoveanu Z; Raska M
    Clin Immunol; 2016 Nov; 172():72-77. PubMed ID: 27444044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.